UPDATED Dec 23, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$1.78 | -14.0% | -2.2% | US$458.4m | US$4.81 | PB0.6x | E157.8% | n/a | ||
IXHL | US$0.40 | -1.9% | -76.9% | US$139.7m | n/a | PS11644.7x | E126.5% | n/a | ||
TLRY | US$10.53 | -18.2% | -25.3% | US$1.2b | US$16.17 | PS1.5x | E123.8% | n/a | ||
HBIO | US$0.72 | -8.4% | -65.3% | US$32.1m | US$2.00 | PB2.3x | E121.8% | n/a | ||
AVTR | US$11.27 | 0.6% | -47.2% | US$7.7b | US$13.32 | PS1.2x | E113.7% | n/a | ||
ORGO | US$5.75 | 9.1% | 80.8% | US$729.7m | US$8.50 | PS1.6x | E104.2% | n/a | ||
AMRN | US$13.66 | -0.5% | 49.6% | US$284.0m | US$12.00 | PS1.3x | E94.5% | n/a | ||
EBS | US$12.54 | 2.9% | 51.1% | US$672.8m | US$13.50 | PE8.7x | E91.3% | n/a | ||
VTRS | US$12.02 | 2.7% | -3.1% | US$13.8b | US$12.44 | PB0.9x | E85.6% | 4.0% | ||
AYTU | US$2.54 | -1.2% | 69.3% | US$25.9m | US$9.33 | PB1.1x | E83.6% | n/a | ||
SBFM | US$1.31 | -5.8% | -59.6% | US$6.4m | US$6.00 | PB0.3x | E83.5% | n/a | ||
SNOA | US$3.58 | 0.8% | 31.1% | US$6.1m | US$13.40 | PB1.6x | E83.1% | n/a | ||
EXAS | US$101.59 | -0.02% | 74.8% | US$19.3b | US$104.56 | PS6.3x | E82.8% | n/a | ||
MDXH | US$3.47 | 10.5% | 62.9% | US$171.8m | US$7.04 | PS1.7x | E81.0% | n/a | ||
AMRX | US$12.84 | 4.1% | 63.6% | US$4.0b | US$14.00 | PE684.1x | E80.1% | 0% | ||
PGEN | US$4.07 | 2.3% | 418.3% | US$1.4b | US$8.50 | PS228.3x | E79.7% | n/a | ||
CAI | US$28.00 | 3.0% | n/a | US$7.9b | US$38.11 | PS12.2x | E78.8% | n/a | ||
JAGX | US$1.09 | -8.4% | -95.8% | US$4.9m | US$25.50 | PB1.6x | E78.1% | n/a | ||
ALDX | US$5.05 | -3.8% | 6.2% | US$303.8m | US$9.67 | PB6.2x | E77.7% | n/a | ||
CLNN | US$6.26 | -4.0% | 25.2% | US$64.7m | US$31.86 | PS302.3x | E77.7% | n/a | ||
TLSI | US$7.05 | -3.4% | 48.4% | US$352.2m | US$11.50 | PS8.8x | E77.5% | n/a | ||
OMER | US$8.75 | -0.9% | -12.5% | US$620.4m | US$28.00 | PE-5.1x | E77.3% | n/a | ||
CAPR | US$28.90 | 10.5% | 106.3% | US$1.5b | US$50.80 | PS134.3x | E76.8% | n/a | ||
OCGN | US$1.40 | -0.7% | 94.9% | US$437.2m | US$9.00 | PS81.4x | E76.8% | n/a |